Exelixis ($EXEL) Insider Trading & Smart Money Activity

Exelixis, Inc. · Biotechnology · Latest filing Jun 25, 2026

Exelixis, Inc. ($EXEL) has 2 13F position changes and 2 analyst ratings on file.

Insider buyers (12 mo)

0

Insider sellers (12 mo)

0

Net insider $ (12 mo)

$0

Congress trades (12 mo)

0

13F moves on file

2

Analyst ratings on file

2

EXEL insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	0	0	0 / 0	0 / 2
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	0	0	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All EXEL insider, congress, 13F and analyst activity

All 13F Analysts

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Jun 25, 2026	Analyst	Truist Securities	Lowers to hold		PT $54		+4.9%	+4.8%			Read
Jun 24, 2026	Analyst	Citizens	Reiterates to buy		PT $55		+2.1%	+4.7%			Read
May 15, 2026	13F	Farallon Capital Management	Reduced	-2.60M sh	$713.37M		0.0%	+5.7%			Read
May 15, 2026	13F	Farallon Capital Management	Reduced	-2.60M sh	$696.59M		0.0%	+5.7%			—

1W / 1M / 6M = how EXEL moved from the trade or filing date.

Institutions moving EXEL (13F)

• Farallon Capital Management2

Analyst ratings on EXEL

Date	Firm	Action	Rating	Price target	1W	1M	6M	Story
Jun 25, 2026	Truist Securities	Lowers	hold	$54	+4.9%	+4.8%		Read
Jun 24, 2026	Citizens	Reiterates	buy	$55	+2.1%	+4.7%		Read

Frequently asked questions

Which institutions changed their EXEL positions?

Recent 13F filers moving the stock include Farallon Capital Management.

Other biotechnology stocks

• $HALO
• $SMMT
• $BBIO
• $ASND
• $JAZZ
• $BMRN
• $MDGL
• $CORT

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.